We blogged about Section 17(b) compliance some months ago. Since then some friends in the market have asked what we would recommend as best practices, and although, as always, this isn’t legal advice, here’s a useful starting point to develop your own best practices.
Navigating the SEC’s Action Against Zymergen: Key Takeaways on Market Size Disclosures
On September 13, 2024, the SEC settled charges against Zymergen